Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 19, 2018

DrugPatentWatch Database Preview

Formulation information for generic ingredient: canagliflozin

« Back to Dashboard

Canagliflozin

CASRN: 842133-18-0UNII:

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture

QuintilesIMS

Teva

US Army

Chinese Patent Office

UBS

Julphar

Covington

Moodys